Home
Home

biotech

Biotech R&D Is Up, But The Struggle Continues

Biotech R&D Is Up, But The Struggle Continues
Pharmalot
Submitted by moderatorj on Fri, 05/18/2012 - 18:53

M&A Activity and a Growing Rate of FDA Approvals Contributing Factors to Biotech Industry's Success The Paragon Report Provides Stock Research on AEterna Zentaris and Celsion

M&A Activity and a Growing Rate of FDA Approvals Contributing Factors to Biotech Industry's Success The Paragon Report Provides Stock Research on AEterna Zentaris and Celsion
Yahoo/MarketWire

Biotech venture rounds dwindle in Europe, tracking U.S. trend

Biotech venture rounds dwindle in Europe, tracking U.S. trend
Fierce Biotech

Growing drug demand means high times for global biotech

Growing drug demand means high times for global biotech
NASDAQ.com

For Biotech Takeovers, Timing is Key

For Biotech Takeovers, Timing is Key
TheStreet.com

Controversial JOBS Act Will Boost Biotech

Controversial JOBS Act Will Boost Biotech
Motley Fool

[video] The Next Big Thing in Biotech: BIO CEO Conference

[video] The Next Big Thing in Biotech: BIO CEO Conference
TheStreet.com

FDA releases long-awaited plan to review first generic versions of pricey biotech drugs

FDA releases long-awaited plan to review first generic versions of pricey biotech drugs
Yahoo/AP

Biogen Idec: The Patriots of Biotechs

Biogen Idec: The Patriots of Biotechs
PharmExec

Biotechnology Funding Hits 4-Year High

Biotechnology Funding Hits 4-Year High
Bloomberg